Kaufmann Gunnar F. 4
4 · Oncternal Therapeutics, Inc. · Filed Jun 14, 2023
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2023-06-12$0.35/sh+25,000$8,745→ 91,726 total - Purchase
Common Stock
2023-06-14$0.36/sh+3,000$1,079→ 94,726 total
Footnotes (1)
- [F1]The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.3448 to $0.3500. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.